These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 37544725)
1. [RNA splicing dysregulation in hematological malignancies]. Yoshida M; Yamauchi H; Sakumoto M; Yoshimi A Rinsho Ketsueki; 2023; 64(7):646-653. PubMed ID: 37544725 [TBL] [Abstract][Full Text] [Related]
2. Splicing Factor Mutations in Cancer. Bejar R Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388 [TBL] [Abstract][Full Text] [Related]
3. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Makishima H; Visconte V; Sakaguchi H; Jankowska AM; Abu Kar S; Jerez A; Przychodzen B; Bupathi M; Guinta K; Afable MG; Sekeres MA; Padgett RA; Tiu RV; Maciejewski JP Blood; 2012 Apr; 119(14):3203-10. PubMed ID: 22323480 [TBL] [Abstract][Full Text] [Related]
4. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations. Pellagatti A; Armstrong RN; Steeples V; Sharma E; Repapi E; Singh S; Sanchi A; Radujkovic A; Horn P; Dolatshad H; Roy S; Broxholme J; Lockstone H; Taylor S; Giagounidis A; Vyas P; Schuh A; Hamblin A; Papaemmanuil E; Killick S; Malcovati L; Hennrich ML; Gavin AC; Ho AD; Luft T; Hellström-Lindberg E; Cazzola M; Smith CWJ; Smith S; Boultwood J Blood; 2018 Sep; 132(12):1225-1240. PubMed ID: 29930011 [No Abstract] [Full Text] [Related]
5. Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches. Armstrong RN; Steeples V; Singh S; Sanchi A; Boultwood J; Pellagatti A Adv Biol Regul; 2018 Jan; 67():13-29. PubMed ID: 28986033 [TBL] [Abstract][Full Text] [Related]
6. Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome. Hong JY; Seo JY; Kim SH; Jung HA; Park S; Kim K; Jung CW; Kim JS; Park JS; Kim HJ; Jang JH Anticancer Res; 2015 May; 35(5):3081-9. PubMed ID: 25964599 [TBL] [Abstract][Full Text] [Related]
7. Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndrome. Mian SA; Smith AE; Kulasekararaj AG; Kizilors A; Mohamedali AM; Lea NC; Mitsopoulos K; Ford K; Nasser E; Seidl T; Mufti GJ Haematologica; 2013 Jul; 98(7):1058-66. PubMed ID: 23300180 [TBL] [Abstract][Full Text] [Related]
8. Aberrant RNA splicing and therapeutic opportunities in cancers. Yamauchi H; Nishimura K; Yoshimi A Cancer Sci; 2022 Feb; 113(2):373-381. PubMed ID: 34812550 [TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors. Je EM; Yoo NJ; Kim YJ; Kim MS; Lee SH Int J Cancer; 2013 Jul; 133(1):260-5. PubMed ID: 23280334 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations. Liu YC; Illar GM; Bailey NG J Clin Pathol; 2020 Nov; 73(11):728-736. PubMed ID: 32217616 [TBL] [Abstract][Full Text] [Related]
14. Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes. Madan V; Li J; Zhou S; Teoh WW; Han L; Meggendorfer M; Malcovati L; Cazzola M; Ogawa S; Haferlach T; Yang H; Koeffler HP Am J Hematol; 2020 Feb; 95(2):133-143. PubMed ID: 31680297 [TBL] [Abstract][Full Text] [Related]
15. Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms. Brierley CK; Steensma DP Curr Hematol Malig Rep; 2016 Dec; 11(6):408-415. PubMed ID: 27492253 [TBL] [Abstract][Full Text] [Related]
16. Splicing factor mutations in the myelodysplastic syndromes: Role of key aberrantly spliced genes in disease pathophysiology and treatment. Pellagatti A; Boultwood J Adv Biol Regul; 2023 Jan; 87():100920. PubMed ID: 36216757 [TBL] [Abstract][Full Text] [Related]
17. Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Lee SC; Dvinge H; Kim E; Cho H; Micol JB; Chung YR; Durham BH; Yoshimi A; Kim YJ; Thomas M; Lobry C; Chen CW; Pastore A; Taylor J; Wang X; Krivtsov A; Armstrong SA; Palacino J; Buonamici S; Smith PG; Bradley RK; Abdel-Wahab O Nat Med; 2016 Jun; 22(6):672-8. PubMed ID: 27135740 [TBL] [Abstract][Full Text] [Related]
18. Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1. Zhang J; Ali AM; Lieu YK; Liu Z; Gao J; Rabadan R; Raza A; Mukherjee S; Manley JL Mol Cell; 2019 Oct; 76(1):82-95.e7. PubMed ID: 31474574 [TBL] [Abstract][Full Text] [Related]
19. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors. Scott LM; Rebel VI J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622 [TBL] [Abstract][Full Text] [Related]
20. Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies. Taylor J; Lee SC Genes Chromosomes Cancer; 2019 Dec; 58(12):889-902. PubMed ID: 31334570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]